[Form 4] Longeveron Inc. Insider Trading Activity

Rhea-AI Filing Summary

Baluch Khoso, a director of Longeveron Inc. (LGVN), reported an insider purchase on 08/11/2025. The filing shows he acquired 11,766 Class A common shares together with 29,415 Class A common warrants at a combined purchase price of $0.85 per share-plus-warrants package. After the transaction, the report lists 52,516 Class A common shares beneficially owned directly.

The warrants are exercisable immediately and expire on 08/11/2027. The Form 4 was signed by an attorney-in-fact on 08/13/2025.

Insights

Financial Analyst

TL;DR: Director purchased shares and warrants on 08/11/2025, increasing direct holdings to 52,516 shares.

The reported purchase of 11,766 Class A shares with accompanying 29,415 warrants at a combined price of $0.85 is a clear insider investment signal documented on a Form 4. For investors, the transaction increases the director's direct stake to 52,516 shares. The warrants are exercisable now and expire on 08/11/2027, which could lead to potential dilution if exercised but also shows commitment by the reporting person to retain economic exposure.

Corporate Governance Expert

TL;DR: Transaction is a routine, disclosed insider purchase; documentation and signature are in order.

The Form 4 discloses a purchase under Rule 16(a) reporting: the combined share-and-warrant package and explicit pricing ($0.85) are provided, and the filing is signed by an attorney-in-fact on 08/13/2025. As a director, the reporting person properly reported the direct acquisition and the resulting beneficial ownership. There is no indication in this filing of any amendment, sale, or derivative disposal that would raise governance concerns.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Baluch Khoso

(Last) (First) (Middle)

1951 NW 7TH AVENUE SUITE 520

(Street)

MIAMI FL 33136

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Longeveron Inc. [ LGVN ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
08/11/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Class A Common Stock	08/11/2025		P		11,766	A	(1)	52,516	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Warrant (right to buy)	$0.85	08/11/2025		P		29,415		08/11/2025	08/11/2027	Class A Common Stock	29,415	(1)	29,415	D

Explanation of Responses:

1. The combined purchase price for each share of Class A Common Stock and accompanying two and one-half Class A Common Warrants was $0.85.

Remarks:

	/s/ Paul Lehr, attorney-in-fact	08/13/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did Baluch Khoso purchase in the LGVN Form 4?

On 08/11/2025 he purchased 11,766 Class A common shares and 29,415 Class A common warrants as reported on the Form 4.

At what price were the LGVN share-and-warrant packages purchased?

The filing states a combined purchase price of $0.85 for each share together with the accompanying 2.5 warrants.

How many LGVN shares does the director beneficially own after the transaction?

The Form 4 lists 52,516 Class A common shares beneficially owned following the reported transaction (direct ownership).

What are the terms and expiration of the warrants acquired in the LGVN filing?

The warrants cover 29,415 underlying shares, are exercisable on 08/11/2025, and expire on 08/11/2027.

When was the Form 4 signed and filed?

The signature block shows the Form 4 was signed by an attorney-in-fact on 08/13/2025.